MicroRNAs in breast cancer research: Progress and promise

Breast Cancer Metastasis and Drug Resistance: Progress and Prospects

Volumn , Issue , 2013, Pages 399-413

  Ahmed, Alia ^a   Ali, Ashhar S ^a   Ali, Shadan ^b   Ahmad, Aamir ^a   Philip, Philip A ^b   Sarkar, Fazlul H ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

Chemotherapy; Let 7 family; Metastasis; miRNA; miRNA 200 family; Natural agents; Oncogene; Radiation; Therapies; Treatments; Triple negative breast cancer cells; Tumor suppressor

Indexed keywords

EID: 84949179298     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-5647-6_22     Document Type: Chapter

References (73)

1. Lynam-Lennon N, Maher SG, Reynolds JV (2009) The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84: 55-71
2. Iorio MV, Casalini P, Piovan C et al (2011) Breast cancer and microRNAs: therapeutic impact. Breast 20(3): S63-S70
3. Mirnezami AH, Pickard K, Zhang L et al (2009) MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol 35: 339-347
4. Kim VN, Nam JW (2006) Genomics of microRNA. Trends Genet 22: 165-173
5. Ali AS, Ali S, Ahmad A, Philip A, Sarkar FH (2011) MicroRNAs in cancer invasion and metastasis. Springer Science, New York
6. Sarkar FH, Li Y, Wang Z et al (2010) Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 13: 57-66
7. Andorfer CA, Necela BM, Thompson EA et al (2011) MicroRNA signatures: clinical biomarkers for the diagnosis and treatment of breast cancer. Trends Mol Med 17: 313-319
8. Jensen EV, Cheng G, Palmieri C et al (2001) Estrogen receptors and proliferation markers in primary and recurrent breast cancer. Proc Natl Acad Sci USA 98: 15197-15202
9. Sugiura H, Toyama T, Hara Y et al (2007) Expression of estrogen receptor beta wild-type and its variant ERbetacx/beta2 is correlated with better prognosis in breast cancer. Jpn J Clin Oncol 37: 820-828
10. Paris O, Ferraro L, Grober OM et al (2012) Direct regulation of microRNA biogenesis and expression by estrogen receptor beta in hormone-responsive breast cancer. Oncogene 4196-4206
11. Lazennec G, Bresson D, Lucas A et al (2001) ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142: 4120-4130
12. Paruthiyil S, Parmar H, Kerekatte V et al (2004) Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G2 cell cycle arrest. Cancer Res 64: 423-428
13. Shaaban AM, Green AR, Karthik S et al (2008) Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients. Clin Cancer Res 14: 5228-5235
14. Guttilla IK, Adams BD, White BA (2012) ERalpha, microRNAs, and the epithelialmesenchymal transition in breast cancer. Trends Endocrinol Metab 23: 73-82
15. Cochrane DR, Spoelstra NS, Richer JK (2012) The role of miRNAs in progesterone action. Mol Cell Endocrinol 357: 50-59
16. Radojicic J, Zaravinos A, Vrekoussis T et al (2011) MicroRNA expression analysis in triplenegative (ER, PR and Her2/neu) breast cancer. Cell Cycle 10: 17-507
17. Ahmad A, Ali AS, Ali S, Wang Z, Kong D, Sarkar FH (2011) MicroRNAs: targets of interest in breast cancer research. Nova Science Publishers, New York
18. Le QJ, Caldas C (2010) Micro-RNAs and breast cancer. Mol Oncol 4: 230-241
19. Sempere LF, Christensen M, Silahtaroglu A et al (2007) Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67: 11612-11620
20. Yu F, Yao H, Zhu P et al (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 23-1109
21. Boyerinas B, Park SM, Hau A et al (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36
22. Park SM, Gaur AB, Lengyel E et al (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907
23. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601
24. Dykxhoorn DM, Wu Y, Xie H et al (2009) miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS ONE 4: e7181
25. Iorio MV, Casalini P, Piovan C et al (2009) microRNA-205 regulates HER3 in human breast cancer. Cancer Res 69: 2195-2200
26. Edmonds MD, Hurst DR, Vaidya KS et al (2009) Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 125: 1778-1785
27. Li W, Duan R, Kooy F et al (2009) Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet 46: 358-360
28. Saetrom P, Biesinger J, Li SM et al (2009) A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 69: 7459-7465
29. Le QJ, Jones J, Warren J et al (2012) Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridisation analysis of micro-RNA expression in arrays of archival tumour tissue. J Pathol 1-28. doi: 10. 1002/path. 3983
30. Augoff K, McCue B, Plow EF et al (2012) miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 11: 5
31. Sossey-Alaoui K, Downs-Kelly E, Das M et al (2011) WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 129: 1331-1343
32. Yu Z, Wang C, Wang M et al (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182: 509-517
33. Yu Z, Willmarth NE, Zhou J et al (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107: 8231-8236
34. Bourguignon LY, Wong G, Earle C et al (2010) Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem 285: 36721-36735
35. Haque I, Banerjee S, Mehta S et al (2011) Cysteine-rich 61-connective tissue growth factornephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells. J Biol Chem 286: 43475-43485
36. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688
37. Gee HE, Camps C, Buffa FM et al (2008) MicroRNA-10b and breast cancer metastasis. Nature 455: 8-9
38. Jiang S, Zhang HW, Lu MH et al (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127
39. Ma L, Young J, Prabhala H et al (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256
40. Onder TT, Gupta PB, Mani SA et al (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654
41. Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210
42. Yu F, Yao H, Zhu P et al (2007) Let-7 regulates self renewal and tumorigenicity of breast cancer cells. Cell 131: 23-1109
43. Boyerinas B, Park SM, Hau A et al (2010) The role of let-7 in cell differentiation and cancer. Endocr Relat Cancer 17: F19-F36
44. Park SM, Gaur AB, Lengyel E et al (2008) The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 22: 894-907
45. Gregory PA, Bert AG, Paterson EL et al (2008) The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593-601
46. Dykxhoorn DM, Wu Y, Xie H et al (2009) miR-200 enhances mouse breast cancer cell colonization to form distant metastases. PLoS ONE 4: e7181
47. Iorio MV, Casalini P, Piovan C et al (2009) microRNA-205 regulates HER3 in human breast cancer. Cancer Res 69: 2195-2200
48. Edmonds MD, Hurst DR, Vaidya KS et al (2009) Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 125: 1778-1785
49. Li W, Duan R, Kooy F et al (2009) Germline mutation of microRNA-125a is associated with breast cancer. J Med Genet 46: 358-360
50. Saetrom P, Biesinger J, Li SM et al (2009) A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res 69: 7459-7465
51. Le QJ, Jones J, Warren J et al (2012) Biological and prognostic associations of miR-205 and let-7b in breast cancer revealed by in situ hybridisation analysis of micro-RNA expression in arrays of archival tumour tissue. J Pathol 1-28. doi: 10. 1002/path. 3983
52. Augoff K, McCue B, Plow EF et al (2012) miR-31 and its host gene lncRNA LOC554202 are regulated by promoter hypermethylation in triple-negative breast cancer. Mol Cancer 11: 5
53. Sossey-Alaoui K, Downs-Kelly E, Das M et al (2011) WAVE3, an actin remodeling protein, is regulated by the metastasis suppressor microRNA, miR-31, during the invasion-metastasis cascade. Int J Cancer 129: 1331-1343
54. Yu Z, Wang C, Wang M et al (2008) A cyclin D1/microRNA 17/20 regulatory feedback loop in control of breast cancer cell proliferation. J Cell Biol 182: 509-517
55. Yu Z, Willmarth NE, Zhou J et al (2010) microRNA 17/20 inhibits cellular invasion and tumor metastasis in breast cancer by heterotypic signaling. Proc Natl Acad Sci USA 107: 8231-8236
56. Bourguignon LY, Wong G, Earle C et al (2010) Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem 285: 36721-36735
57. Haque I, Banerjee S, Mehta S et al (2011) Cysteine-rich 61-connective tissue growth factornephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1alpha-TWIST signaling networks in human breast cancer cells. J Biol Chem 286: 43475-43485
58. Ma L, Teruya-Feldstein J, Weinberg RA (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688
59. Gee HE, Camps C, Buffa FM et al (2008) MicroRNA-10b and breast cancer metastasis. Nature 455: 8-9
60. Jiang S, Zhang HW, Lu MH et al (2010) MicroRNA-155 functions as an OncomiR in breast cancer by targeting the suppressor of cytokine signaling 1 gene. Cancer Res 70: 3119-3127
61. Ma L, Young J, Prabhala H et al (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247-256
62. Onder TT, Gupta PB, Mani SA et al (2008) Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 68: 3645-3654
63. Huang Q, Gumireddy K, Schrier M et al (2008) The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 10: 202-210
64. Ma L, Weinberg RA (2008) Micromanagers of malignancy: role of microRNAs in regulating metastasis. Trends Genet 24: 448-456
65. Valastyan S (2012) Roles of microRNAs and other non-coding RNAs in breast cancer metastasis. J Mammary Gland Biol Neoplasia 17: 23-32
66. Neelakandan K, Babu P, Nair S (2012) Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Curr Cancer Drug Targets 716-740
67. Lee YS, Dutta A (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025-1030
68. Johnson SM, Grosshans H, Shingara J et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120: 635-647
69. Mayr C, Hemann MT, Bartel DP (2007) Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 315: 1576-1579
70. Park SM, Shell S, Radjabi AR et al (2007) Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6: 2585-2590
71. Kong W, He L, Coppola M et al (2010) MicroRNA-155 regulates cell survival, growth, and chemosensitivity by targeting FOXO3a in breast cancer. J Biol Chem 285: 17869-17879
72. Foekens JA, Sieuwerts AM, Smid M et al (2008) Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc Natl Acad Sci USA 105: 13021-13026
73. Camps C, Buffa FM, Colella S et al (2008) hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14: 1340-1348